Mid Atlantic Capital Management, Inc. Abb Vie Inc. Transaction History
Mid Atlantic Capital Management, Inc.
- $137 Billion
- Q4 2024
A detailed history of Mid Atlantic Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mid Atlantic Capital Management, Inc. holds 200 shares of ABBV stock, worth $38,068. This represents 0.03% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$38,068
Previous $39.5 Million
10.02%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,958Shares Held
1.26BCall Options Held
16.9MPut Options Held
13M-
Vanguard Group Inc Valley Forge, PA172MShares$32.7 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.96 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.37 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $337B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...